Picture of Diaceutics logo

DXRX Diaceutics Share Price

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapHigh Flyer

Momentum

Relative Strength (%)
1m+3.76%
3m+0.51%
6m+16.26%
1yr+12.7%
Volume Change (%)
10d/3m-80.52%
Price vs... (%)
52w High-6.99%
50d MA-1.63%
200d MA+15.13%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)163.12
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value3.41
Price to Tang. Book4.74
Price to Free Cashflown/a
Price to Sales4.52
EV to EBITDA52.47

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-9.27%
Return on Equity-4.72%
Operating Margin-12.73%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Diaceutics EPS forecast chart

Profile Summary

Diaceutics PLC is a United Kingdom-based technology and solutions provider to pharma and biotech companies. It is engaged in research and development activities in the area of drug development science, precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions and Scientific & Advisory Services. Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    May 17th, 2005
    Public Since
    March 21st, 2019
    No. of Employees
    184
    Sector
    Professional & Commercial Services
    Industry
    Industrials
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    84,726,935

    DXRX Share Price Performance

    Upcoming Events for DXRX

    Half Year 2024 Diaceutics PLC Earnings Release

    Half Year 2024 Diaceutics PLC Earnings Presentation

    Half Year 2024 Diaceutics PLC Analyst Presentation

    Similar to DXRX

    Picture of ADVFN logo

    ADVFN

    gb flag iconLondon Stock Exchange

    Picture of Andrews Sykes logo

    Andrews Sykes

    gb flag iconLondon Stock Exchange

    Picture of Anexo logo

    Anexo

    gb flag iconLondon Stock Exchange

    Picture of Ashtead logo

    Ashtead

    gb flag iconLondon Stock Exchange

    Picture of Ashtead Technology Holdings logo

    Ashtead Technology Holdings

    gb flag iconLondon Stock Exchange

    FAQ